Knowledge hub

Leading with purpose: Łukasz Nowak on building strong teams and scalable operations
Blog

Leading with purpose: Łukasz Nowak on building strong teams and scalable operations

From patient data to novel targets and biomarkers: UK Biobank use
AI with impact: CTO Michał Warchoł on building tech that matters
From research to impact: Ardigen’s technology behind the Polish Microbiome Map
Your monthly AI in biotech digest – November
Laboratory glassware with digital data visualization overlay, representing the use of public biological datasets for AI-driven drug discovery.
Leveraging Public Datasets for AI-Driven Discovery
Stage view from the SBI² 2025 conference in Boston, showing the event banner and audience.
SBI² 2025 Recap: From Cells to Systems – Imaging, AI, and the Future of Phenotypic Discovery
A Decade of Ardigen
A Decade of Ardigen: Celebrating 10 Years of People, Science & Shared Purpose
AI transformation in clinical trials faces hurdles like data quality, bias, and scalability. Know the challenges and their corresponding sol
Blog

Challenges of AI in clinical trials and how to overcome them

New joint study: Computational identification of cross-reactive TCR epitopes with ARDitox
Adding Space to the Equation: How Spatial Context Enhances Drug Discovery
Where Biology Meets Data: Key Takeaways from Festival of Biologics & BioTechX 2025
Poster: Initial Insights into Cost-Efficient AI Toxicity Profiling: Cell Painting + Chemical Structures
Can AI Stop the Cost Spiral in Drug Discovery? Summary of Our Expert Talk at BioTech X 2025
Your monthly AI in biotech digest – October
Abstract visualization of AI-driven analysis of patient data, representing precision medicine and responder identification.
Precision Trials: Using AI to Identify Responders
Poster: Safer pHLA-Targeted Immunotherapies Through AI and Computational Immunology